Dr. Julio C Barredo, MD
Claim this profileUniversity of Miami Miller School of Medicine-Sylvester Cancer Center
Expert in Tumors
Expert in Neuroblastoma
45 reported clinical trials
95 drugs studied
About Julio C Barredo, MD
Education:
- Earned an MD from the University of Miami Miller School of Medicine.
- Completed a Residency in Internal Medicine at Jackson Memorial Hospital.
- Undertook a Fellowship in Hematology and Oncology at the Sylvester Comprehensive Cancer Center.
Experience:
- Serves as an Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine.
- Works as a medical oncologist at the Sylvester Comprehensive Cancer Center.
Area of expertise
1Tumors
Global LeaderStage I
Stage II
Stage IV
2Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
Affiliated Hospitals
Clinical Trials Julio C Barredo, MD is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Julio C Barredo, MD
Clinical Trial Related7 years of experience running clinical trials · Led 45 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Julio C Barredo, MD has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Carboplatin
- Doxorubicin Hydrochloride
Breakdown of trials Julio C Barredo, MD has run
Tumors
Neuroblastoma
Brain Tumor
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Julio C Barredo, MD specialize in?
Julio C Barredo, MD focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Julio C Barredo, MD currently recruiting for clinical trials?
Yes, Julio C Barredo, MD is currently recruiting for 12 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Julio C Barredo, MD has studied deeply?
Yes, Julio C Barredo, MD has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Julio C Barredo, MD?
Apply for one of the trials that Julio C Barredo, MD is conducting.
What is the office address of Julio C Barredo, MD?
The office of Julio C Barredo, MD is located at: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami Miller School of Medicine-Sylvester Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.